MUSTANG BIO, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
MUSTANG BIO, INC. (MBIO) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$20.61 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-14
- MUSTANG BIO, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$20.24M.
- MUSTANG BIO, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$375.00K.
- MUSTANG BIO, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was $0.00.
- MUSTANG BIO, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was $0.00.
- MUSTANG BIO, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $0.00.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 7 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 10 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|---|---|
| 2017-06-30 | -$20.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$20.61M 10-Q · filed 2017-08-14 | -$20.61M derived: sum of 3 quarters · filed 2017-08-14 | -$20.61M derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2017-03-31 | -$375.00K 10-Q · filed 2017-05-15 | -$375.00K derived: sum of 2 quarters · filed 2017-05-15 | -$375.00K derived: sum of 3 quarters · filed 2017-05-15 | -$375.00K derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $0.00 derived: sum of 2 quarters · filed 2017-03-31 | $0.00 derived: sum of 3 quarters · filed 2017-08-14 | $0.00 10-K · filed 2017-03-31 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-08-14 | $0.00 10-Q · filed 2016-11-14 | |||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | ||||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-15 | |||||
| 2015-12-31 | -$2.00M 10-K · filed 2017-03-31 | |||||
| 2015-09-30 | -$2.00M 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |